1. Volume 68, Issue 5, Pages 885-890 (November 2015)
Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer 
Carlotta Buzzoni, Anssi Auvinen, Monique J. Roobol, Sigrid Carlsson, Sue M. Moss, Donella Puliti, Harry J. de Koning, Chris H. Bangma, Louis J. Denis, Maciej Kwiatkowski, Marcos Lujan, Vera Nelen, Alvaro Paez, Marco Randazzo, Xavier Rebillard, Teuvo L.J. Tammela, Arnauld Villers, Jonas Hugosson, Fritz H. Schröder, Marco Zappa 
European Urology 
Volume 68, Issue 5, Pages (November 2015)
DOI: /j.eururo
Copyright © 2015 European Association of Urology Terms and Conditions

2. Fig. 1
Cumulative incidence rate ratios for risk category 4 (after data imputation) and cumulative prostate cancer mortality rate ratio by time since randomisation (95% confidence intervals given in parentheses).
IRD=incidence rate difference per 1000 randomised men; MRD=mortality rate difference per 1000 randomised men.
European Urology  , DOI: ( /j.eururo )
Copyright © 2015 European Association of Urology Terms and Conditions